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CONSPECTUS:
The ever-present demand for drugs with better efficacy and fewer side effects continually 
motivates scientists to explore the vast chemical space. Traditionally, medicinal chemists have 
focused much attention on achiral or so-called “flat” molecules. More recently, attention has 
shifted toward molecules with stereogenic centers since their three-dimensional structures 
represent a much larger fraction of the chemical space and have a number of superior properties 
compared with flat aromatic compounds. Quaternary stereocenters, in particular, add greatly to the 
three-dimensionality and novelty of the molecule. Nevertheless, synthetic challenges in building 
quaternary stereocenters have largely prevented their implementation in drug discovery. The lack 
of effective and broadly general methods for enantioselective formation of quaternary 
stereocenters in simple molecular scaffolds has prompted us to investigate new chemistry and 
develop innovative tools and solutions. In this Account, we describe three approaches to 
constructing quaternary stereocenters: nucleophilic substitution of 3-haloindoles, conjugate 
addition of boronic acids to cyclic enones, and allylic alkylation of enolates. In the first approach, 
malonic ester nucleophiles attack electrophilic 3-halooxindoles, mediated by a copper(II)-
bisoxazoline catalyst. A variety of oxindoles containing a benzylic quaternary stereocenter can be 
accessed through this method. However, it is only applicable to the specialized 3,3-disubstituted 
oxindole system. To access benzylic quaternary stereocenters in a more general context, we turned 
our attention to the enantioselective conjugate addition of carbon nucleophiles to α,β-unsaturated 
carbonyl acceptors. We discovered that in the presence of catalytic palladium-pyridinooxazoline 
complex, arylboronic acids add smoothly to β-substituted cyclic enones to furnish ketones with a 
β-benzylic quaternary stereocenter in high yields and enantioselectivities. The reaction is 
compatible with a wide range of arylboronic acids, β-substituents, and ring sizes. Aside from 
benzylic quaternary stereocenters, a more challenging motif is a quaternary stereocenter not 
adjacent to an aromatic group. Such centers represent more general structures in chemical space, 
but are more difficult to form by asymmetric catalysis. To address this greater challenge, and 
motivated by the greater reward, we entered the field of palladium-catalyzed asymmetric allylic 
alkylation of prochiral enolate nucleophiles about a decade ago. On the basis of Tsuji’s work, 
which solved the issue of positional selectivity for unsymmetrical ketones, we discovered that the 
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phosphinooxazoline ligand effectively rendered this reaction enantioselective. Extensive 
investigations since then have revealed that the reaction exhibits broad scope and accepts a range 
of substrate classes, each with its unique advantage in synthetic applications. A diverse array of 
carbonyl compounds bearing α-quaternary stereocenters are obtained in excellent yields and 
enantioselectivities, and more possibilities have yet to be explored. As an alternative to palladium 
catalysis, we also studied iridium-catalyzed asymmetric allylic alkylations that generate vicinal 
quaternary and tertiary stereocenters in a single transformation. Overall, these methods provide 
access to small molecule building blocks with a single quaternary stereocenter, can be applied to 
various molecular scaffolds, and tolerate a wide range of functional groups. We envision that the 
chemistry reported in this Account will be increasingly useful in drug discovery and design.
Graphical Abstract
1. Introduction
As humanity settles into the second decade of the 21st Century, science continues to press 
forward with new advances that alter our experiences on a daily basis. The fields of 
medicinal and pharmaceutical chemistry are no different, with new medicines becoming 
available to treat the most threatening and problematic maladies of the day. Although the 
landscape of drug discovery and the pharmaceutical industry continue to change, particularly 
with the vibrant increase in new types of large molecule medicinal agents, small molecule 
chemistry is likely to continue to play a critical role in the discovery of new active 
pharmaceutical ingredients (API) well into the future. Therefore, it is critical that academic 
chemists continue to develop thoughtful strategies, implement sound tactical maneuvers, and 
invent robust new technologies for the synthesis of biologically rich, complex small 
molecules that will allow medicinal chemists to explore new molecular space with 
functional compounds having better properties.
For many years, medicinal chemists have focused attention on achiral aromatic and 
heteroaromatic molecules as potential drug candidates.1 This is in part due to the relative 
ease of their preparation, especially since the emergence of cross-coupling chemistries and 
parallel synthesis, and their biased population in screening suites at most companies. While 
many of such compounds have been developed into successful drugs, their lack of 
stereochemistry presents a number of drawbacks at a fundamental level. First, achiral or 
“flat” molecules occupy only a small fraction of chemical space. From a structural diversity 
perspective, a vast number of possibilities have not been explored. Second, the two-
dimensional nature of aromatic molecules implies that their interaction with target proteins, 
which have a three-dimensional structure, will be limited. Therefore, high selectivity for 
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binding to the desired protein (for instance) over undesired ones is difficult to achieve, and 
side effects such as cytotoxicity often pose a challenge. Finally, polyaromatic molecules tend 
to interact strongly with one another due to π-stacking, thereby resulting in low solubility 
and poor bioavailability.
A promising solution to the issues raised above is to incorporate sp3-hybridized carbon 
stereocenters into the molecule. This topic has been the subject of recent review articles and 
essays.2 In particular, quaternary stereocenters, which bear four different carbon substituents 
at the four vertices of a tetrahedron, add greatly to the three-dimensionality of a molecule. 
However, construction of quaternary stereocenters via chemical synthesis is extremely 
challenging.3 While 21 compounds out of the top 200 drugs by US retail sales in 20124 have 
quaternary stereocenters (>10%, examples shown in Figure 1), all of those structures are 
derived from natural products. These include terpenoid (1–5 and 9) and morphine (6–8) 
derivatives, where the quaternary stereocenters are made by nature and the API is typically 
produced by peripheral derivatization. Within those 200 top pharmaceuticals, none have a 
quaternary stereocenter built by chemical synthesis. This dichotomy reflects the paucity of 
synthetic methods available for the construction of quaternary stereocenters and 
consequently the lack of their applications in drug discovery.
Traditional chemical approaches to quaternary stereocenters include the Claisen 
rearrangement5 and the Diels–Alder reaction.6 While these reactions are well established, 
the formation of the quaternary stereocenter is often accompanied by formation of other 
stereocenters nearby. From a drug discovery perspective, this potentially introduces 
unnecessary complexity, collaterally obscuring structure-activity relationship (SAR) studies. 
Construction of a single quaternary stereocenter in a simple molecular scaffold is much 
more desirable. Most critical would be to develop robust methods that allow one to perform 
rigorous SAR studies while maintaining the quaternary center as a constant.
During the past decade, our research group has strategically tackled this problem by 
implementing an array of orthogonal approaches. The most well studied tactics that have 
emerged from our laboratories involve the alkylation of 3-halooxindole electrophiles, the 
conjugate addition of boronic acids to cyclic enones, and the allylic alkylation of enolates. In 
all three approaches, we have achieved catalytic asymmetric construction of quaternary 
stereocenters in high yield and enantioselectivity with broad substrate scope. We believe that 
these methods will greatly expand the medicinal chemist’s synthetic toolbox and facilitate 
access to potential drug candidates containing quaternary stereocenters.
2. Enantioselective syntheses of C(3) all carbon quaternary centers on 
oxindoles by alkylation of 3-bromooxindoles
3,3-Disubstituted oxindoles and their derivatives are widely encountered in numerous 
biologically active natural products7 and pharmaceutical compounds.8 A considerable 
amount of effort has thus been devoted toward the construction of 3,3-disubstituted 
oxindoles over the past decade.9,10 However, a non-traditional use of the oxindole core as an 
electrophile rather than as a nucleophile toward the catalytic enantioselective generation of 
C(3) quaternary substituted oxindoles was unprecedented and discovered by our laboratory.
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In 2007, we reported a method for the construction of 3,3-disubstituted oxindoles in good 
yields by alkylation of malonate nucleophiles with 3-halooxindoles as electrophiles, 
presumably via indolones 11 (Scheme 1A).11 Additionally, by employing these mild 
conditions, we could access the core structures of the complex polycyclic alkaloid natural 
products communesin F (19) and perophoramidine (20, Scheme 1B).12 In view of these 
promising results, we turned our attention to the asymmetric synthesis of C(3) all-carbon 
quaternary substituted oxindoles.13 We envisioned that employing a chiral Lewis acid 
catalyst would facilitate an asymmetric variant of our alkylation reactions under mild basic 
conditions. Gratifyingly, we found that smooth enantioselective alkylation of 3-
bromooxindole by malonates was achieved in good yields and high enantioselectivities by 
implementing a chiral Cu•BOX catalyst with a weakly coordinating counter ion such as 
SbF6 (Table 1). A variety of substituted alkyl chain lengths were tolerated in the chemistry, 
as were numerous functional groups. Additionally, 3-aryl-3-chlorooxindoles were also 
alkylated to produce the corresponding 3,3-disubstituted oxindoles in good yields and high 
enantioselectivities. Our method stands as one of the only that allows the preparation of both 
C3-alkyl and C3-aryl quaternary oxindoles with a single catalyst system.
Mechanistically, we envision that prochiral indolone 11 is likely to be an intermediate, since 
racemic starting materials remain throughout the course of the reaction and are converted to 
products of high ee (Scheme 2A), and alkylation reactions employing N-Me oxindole 21 as 
electrophiles are unsuccessful under our standard conditions (Scheme 2B).
3. Palladium-catalyzed asymmetric conjugate addition of arylboronic 
acids to cyclic enones to furnish benzylic quaternary centers
Although the alkylation of malonate nucleophiles to halooxindoles produces a quaternary 
benzylic carbon stereocenter, it does so in a very specialized system, the 3,3-disubstituted 
oxindole series. In order to produce benzylic quaternary centers in a more general way, we 
turned to the catalytic asymmetric conjugate addition of a carbon-based nucleophiles to β-
substituted α,β-unsaturated carbonyl acceptors.14 For transition metal approaches, there 
have been two successful major catalytic systems, copper and rhodium. To date, most 
nucleophiles employed in copper-catalyzed conjugate additions are highly reactive 
organometallic species such as diorganozinc,15 triorganoaluminum,16 and organomagnesium 
reagents.17 The air- and moisture-sensitive nature of these nucleophiles requires strictly 
anhydrous reaction conditions. On the other hand, air-stable organoboron reagents have been 
used in rhodium-catalyzed conjugate additions,18 although there are relatively few examples 
of quaternary stereocenter formation.19 In one report, it was shown that sodium 
tetraarylborates and arylboroxines could add to β,β-disubstituted enones to deliver β-
quaternary ketones.20 From a practical standpoint, using commercially available arylboronic 
acids as nucleophiles will make conjugate addition a much more valuable method for 
quaternary stereocenter generation. Additionally, the ultra-high cost of Rhodium can often 
be prohibitive. As a remedy for these substantial hurdles, we embarked on a program to 
develop Pd catalysts that could be employed with aryl boronic acids for this purpose.
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Palladium-catalyzed conjugate addition of arylboronic acids to enones has been widely 
studied and has led to development of addition reactions that form enantioenriched tertiary 
stereocenters.21 More recently, Lu reported a bipyridine-palladium complex-catalyzed 
conjugate addition to form quaternary stereocenters in racemic form.22 We envisioned that 
by using chiral ligands, enantioselective formation of quaternary stereocenters might be 
achieved.23 With 3-methyl-2-cyclohexenone and phenylboronic acid as model reactants, we 
examined a range of reaction parameters, and discovered that a combination of easily 
accessible chiral pyridinooxazo-line (PyOx) ligand, a commercial palladium(II) 
trifluoroacetate precatalyst, and 1,2-dichloroethane as solvent provided the desired β-
quaternary ketone in high yield and excellent ee. Notably, the reaction was not sensitive to 
oxygen or moisture, and thus could be performed under ambient atmosphere without the 
need for anhydrous solvents.
With the optimal conditions in hand, we explored the substrate scope of palladium-catalyzed 
conjugate addition of arylboronic acids to cyclic enones (Table 2). In addition to a variety of 
substituents on the aromatic ring of the boronic acid, 5-, 6-, and 7-membered cyclic enones 
are all competent substrates for the reaction. Enones bearing more complex substituents at 
the β-position also undergo conjugate addition smoothly to afford the corresponding β-
quaternary ketones in good yields and good to high ee.
During scale-up studies, we found that addition of water was necessary for the complete 
conversion of starting material (Scheme 3). With 5 equiv of water, a 22 mmol scale reaction 
proceeded smoothly to furnish 3-methyl-3-phenylcyclohexanone (33) in 97% yield and 91% 
ee. Further investigation revealed that addition of water and ammonium 
hexafluorophosphate had a synergistic effect in increasing reaction rate. Thus, more 
challenging substrates such as ortho-substituted arylboronic acid could also be employed in 
conjugate addition to give the desired products in much better yields compared with the 
previous conditions (Table 3).24
Finally, a series of experimental and computational mechanistic studies revealed that a likely 
mechanistic path for the reaction is shown in Scheme 4.24 The catalytic cycle consists of 
transmetalation from boron to palladium, insertion of the enone substrate into the arylmetal 
bond, and protonolysis of the resulting palladium-enolate 30. These investigations suggest 
that the bond-forming palladium species is an arylpalladium(II) cation (28), and 
enantioselectivity is governed by steric repulsions between the t-Bu group of the chiral 
ligand and the α-methylene hydrogens of the cyclohexenone substrate.
4. Palladium-Catalyzed Enantioselective Allylic Alkylation of Prochiral 
Enolates
The first two sections of this manuscript discuss benzylic quaternary centers, yet a 
potentially greater challenge to asymmetric catalysis lies in bond forming chemistries that 
have no proximal aromatic groups. It is often the case that asymmetric reactions may 
function at benzylic positions and then fail upon extension to the alkyl variant. For the 
construction of quaternary centers, the case is no different. It was precisely this limitation, 
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and our concomitant efforts in the context of a multi-step synthesis, that guided our entry 
into this entire field, more than a decade ago.25
Palladium-catalyzed asymmetric allylic alkylation is a powerful C–C bond forming process 
that allows for the construction of stereogenic centers.26 A typical catalytic cycle involves 
the oxidative generation of a π-allylpalladium intermediate from an allyl electrophile, 
followed by nucleophilic attack on the allyl terminus, resulting in reduction of the metal 
center (Scheme 5). The pioneering earlier works of Trost,27 Helmchen,28 and others focused 
mainly on prochiral allyl electrophiles. Although this reaction mode enjoys success with a 
broad range of substrates and has found numerous applications in natural products synthesis, 
it typically produces only tertiary stereocenters. Formation of quaternary stereocenters by C-
nucleophilic addition to prochiral allyl electrophiles has been carried out with other metals, 
such as copper.29
Another mode of reactivity makes use of a prochiral nucleophile. A quaternary stereocenter 
may be formed if the nucleophile possesses three distinct substituents. One typical example 
of such nucleophiles is a tetrasubstituted enolate, generated by deprotonation of a carbonyl 
compound. However, position-selective enolate generation can be particularly challenging if 
the carbonyl compound bears multiple, similarly acidic α-protons. For example, 
deprotonation and alkylation of nonsymmetrical ketones generally lead to an intractable 
mixture of positional isomers (Scheme 6A). To address this selectivity issue, two strategies 
have been classically pursued. One of them installs a blocking group at the undesired α-
position (Scheme 6B).30 The other strategy introduces an electron-withdrawing group at one 
of the α-positions to dramatically lower its pfta and stabilize the enolate thus formed 
(Scheme 6C).31 Although these tactics circumvent the positional selectivity problem, they 
require additional functional groups that potentially need removal or manipulation, thus 
reducing overall efficiency and synthetic utility.
We were drawn to the pioneering work of Tsuji to provide an alternative solution to this 
position selectivity problem in the context of enantioselective catalysis. In the early 1980s, 
the Tsuji group reported the non-enantioselective allylic alkylation of silyl enol ethers, enol 
carbonates, and β-ketoesters derived from nonsymmetrical, nonstabilized ketones, in the 
presence of catalytic palladium and phosphine ligand (Scheme 7).32 The first substrate class 
involves separate nucleophiles and electrophiles (Scheme 7A), while the other two classes 
build the latent enolate nucleophile and the allyl electrophile into one molecule (Scheme 7B 
and C). The Tsuji allylic alkylation furnishes simple α-quaternary ketones with high 
positional fidelity, and the reaction proceeds under mild and nearly neutral conditions, with 
no exogenous base required. Despite these important advantages, the Tsuji allylic alkylation 
saw little application in organic synthesis for two decades and no asymmetric version was 
known until our first report in 2004.33
We became interested in developing an enantioselective variant of the Tsuji allylic alkylation 
because of its regiochemical fidelity and the synthetic utility of its products. We envisioned 
that a chiral phosphine ligand might impart asymmetric induction in the reaction, leading to 
preferential formation of one of the enantiomers. With allyl enol carbonate 33 as substrate, 
we examined a number of chiral bidentate phosphine ligands of various scaffolds and 
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different chelating atoms and were pleased to discover that the phosphinooxazoline ligand 
(S)-t-Bu-PHOX (36) provided excellent reactivity and high enantioselectivity (96% yield, 
88% ee; see Scheme 8).
Since this initial discovery, we have intensely investigated the scope of this catalysis and 
found it to be extensive. From a practical standpoint, an important finding was our ability to 
initiate the chemistry starting from a range of substrate classes. Specifically, in addition to 
the prototypical enol allyl carbonate, silyl enol ethers, allyl β-ketoesters, allyl enol ethers, 
and trimethyl silyl ethyl keto esters can serve as nearly equivalent masked enolate substrates 
(Figure 2). The electrophilic allyl unit can bear carbonates, acetates, sulphonates, and in 
some instances even halides as the leaving group. The great flexibility in substrate choice 
allows for strategic implementation in the context of multi-step synthesis, with each 
substrate class engendering different and unique tactical advantages.
A wide array of quaternary ketones with various scaffolds and substituents can be accessed 
through our allylic alkylation chemistry with high yield and enantioselectivity (Table 4).33,34 
Substitutions at the α-position, the 2-allyl position, and on the ring are all well tolerated. 
Substrates with seven- and eight-membered rings undergo the alkylation reaction smoothly. 
In addition to quaternary stereocenters, fully substituted tertiary centers can also be built by 
the reaction.35
During our investigations, we became aware of the ligand electronic effects on reaction rate 
and selectivity. In many cases, the electron-deficient phosphinooxazo-line ligand (S)-(CF3)3-
t-Bu-PHOX (37, Table 5) lead to faster reaction rates and higher enantioselectivities, as 
compared with the standard (S)-t-Bu-PHOX ligand. This modification of ligand electronics 
allowed us to improve the reaction’s performance with more challenging classes of 
substrates such as cyclobutanones36 and lactams.37 Fully substituted tertiary carbonyl 
compounds, such as morpholinones,37 α-fluorolactams,37 and piperazines38 can all be 
obtained through this chemistry.
A mechanistic rationale has been proposed for the catalytic cycle (Scheme 9). Oxidative 
addition of Pd(0) to the allyl–O bond of 34 generates complex 39, which undergoes 
decarboxylation to form allyl palladium enolate 40, a key intermediate that can be formed 
from other starting materials such as silyl enol ether 31 and allyl enol carbonate 33. 
Reductive elimination furnishes quaternary ketone product (–)-35 and regenerates the active 
Pd(0) catalyst 38.
For the past decade, other labs have also contributed significantly to the field with related 
methods. Trost reported related palladium-catalyzed asymmetric allylic alkylation using a 
C2-symmetric diamine-based ligand.39 Nakamura and Paquin each expanded the scope of 
our method for the enantioselective synthesis of α-fluoroketones using the Pd/(S)-t-Bu-
PHOX catalyst system.40 Tunge employed the same catalyst/ligand combination for the 
deacylative allylic alkylation of ketones.41 The requisite allyl palladium enolate species can 
also be generated by fragmentation of fused 5–4 ring systems42 (Scheme 10A) or copper-
catalyzed conjugate addition of silanes to enones (Scheme 10B).43
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Since the reaction involves an enolate nucleophile, we envisioned trapping it with 
electrophiles other than the allyl fragment. Such electrophiles need to meet two 
requirements: 1) they do not interfere with oxidative addition or enolate generation; and 2) 
their reaction with the enolate is faster than direct enolate allylic alkylation. After 
examination of various carbon electrophiles, we found that arylidenemalononitrile-type 
Michael acceptors exhibited desired reactivity and produced cyclic ketones bearing adjacent 
quaternary and tertiary stereocenters (Scheme 11).44
5. Iridium-Catalyzed Allylic Alkylation for the Construction of Vicinal 
Quaternary and Tertiary Stereocenters
Based on the intriguing diastereochemical issues encountered in the Pd-enolate trapping 
chemistry, we became interested in other methods for direct generation of vicinal 
quaternary-tertiary relationships. Recently, by employing prochiral α-substituted cyclic β-
ketoester enolates as nucleophiles, we developed an Ir-catalyzed direct enantioselective 
allylic alkylation reaction for the construction of vicinal quaternary-tertiary arrays.45,46 We 
explored the reaction with commonly used iridium catalyst systems, derived from 
[Ir(cod)Cl]2 and phosphoramidite ligands. The catalyst derived from Feringa ligand (L1)47 
affords the desired branched product in an equal amount of two diastereoisomers (1:1 dr), 
although the ee of the isomers are nearly perfect (96% and 99% ee, respectively; see Scheme 
12).48 In contrast, the [Ir(cod)Cl]2•N-arylphosphoramidite (L3) complex49 was found to 
furnish the desired product in 98% ee, >20:1 dr and excellent branched to linear ratio.
The reaction proceeds with high yield and selectivity using a wide range of substrates 
variable on the enolate portion as well as the electrophile (Table 6). With further exploration, 
we found that a modified protocol is amenable to acyclic β-ketoesters as well, again with 
tolerance to a wide array of substituent groups and functionality (Table 7).50
Combining our fluoride-triggered decarboxylative allylic alkylation51 and the iridium 
chemistry together, we have developed a sequential double allylic alkylation procedure to 
selectively program the diastereomer that is furnished within the stereochemical dyad. We 
found that 2-(trimethylsilyl)ethyl β-ketoester substrates successfully engage in iridium-
catalyzed allylic alkylation to generate the desired product with excellent regio- and 
enantioselectivity. Subsequently, treatment of the product (44) with allyl methyl carbonate 
and catalyst derived from Pd2(dba)3 and PHOX ligand (L4), in the presence of 
tetrabutylammonium difluorotriphenylsilicate (TBAT), generated the desired dialkylated α-
quaternary ketone 45B in good yield and diastereoselectivity (Table 8, entry 1). Through 
choice of ligand, we can alter the selectivity to favor the ketone 45A in high dr (12:1–18:1) 
and yield (80–87%) with several 2-substituted allyl carbonates (entries 2–4).
6. Conclusions
The development of a suite of catalytic asymmetric transformations by our group for the 
preparation of quaternary stereocenters provides access to a broad range of enantioenriched, 
high-value, small molecule building blocks (Figure 3). We have developed methods that 
readily produce 3,3-disubstituted oxindoles, β-quaternary ketones, α-quaternary ketones, 
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and α-quaternary lactams. These building blocks can be further derivatized to a much larger 
collection of compounds bearing quaternary stereogenicity. We anticipate that the synthetic 
methods developed by our group and the advancements that synthetic chemists are making 
as a whole toward the synthesis of challenging stereochemically rich molecules will find 
increasing future application in drug discovery and design. These methods move us into 
previously unexplored chemical space that may be brought to bear on problems of a 
medicinal nature, with potential enhancements in biochemical, pharmacological, and 
physiological properties.
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Figure 1. 
Drug molecules containing quaternary stereocenters.
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Figure 2. 
Substrate possibilities for the enantioselective alkylation reaction.
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Figure 3. 
Enantioenriched building blocks accessible by our synthetic methods.
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Scheme 1. 
Alkylations of 3-halooxindoles.
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Scheme 2. 
Alkylations of 3-halooxindoles via reactive prochiral indolone 11.
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Scheme 3. 
Large scale conjugate additions.
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Scheme 4. 
Mechanistic rationale for the asymmetric conjugate addition.
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Scheme 5. 
General mechanism of Pd-catalyzed Asymmetric Allylic Alkylation.
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Scheme 6. 
Challenges in alkylation of nonsymmetrical ketones.
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Scheme 7. 
The Tsuji allylic alkylation.
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Scheme 8. 
Discovery of an enantioselective catalyst system for the asymmetric Tsuji allylic alkylation.
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Scheme 9. 
Proposed mechanism for palladium-catalyzed allylic alkylation.
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Scheme 10. 
Generation of palladium enolate intermediates from other starting materials.
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Scheme 11. 
Asymmetric enolate alkylation cas-cade with different electrophiles.
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Scheme 12. 
Ir-catalyzed allylic alkylation of cyclic α-substituted β-ketoesters. a (ee) for alternate 
diastereomer.
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Table 1.
Enantioselective alkylation of 3-halooxindoles.
a Used 3-aryl-3-chlorooxindoles as substrates and (S)-PhBox as ligand.
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Table 2.
Asymmetric addition of arylboronic acids to 3-substituted cyclic enones.
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Table 3.
Increased yields under new reaction conditions.
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Table 8.
Sequential allylic alkylation catalyzed by by iridium and palladium complexes.
Ir conditions: [Ir(cod)Cl]2 (2 mol%), L3 (4 mol%), TBD (10 mol%), LiBr (1 equiv), in THF at 25 °C.
Pd conditions: Pd2(dba)3 (5 mol%), ligand (12.5 mol%), TBAT (1.2 equiv), allyl carbonate (1.2 equiv), in THF at 25 °C.
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